These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38314858)

  • 1. Real-World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps.
    Dorling M; Hernaiz-Leonardo JC; Pascual A; Janjua A; Thamboo A; Javer A
    Laryngoscope; 2024 Jul; 134(7):3054-3059. PubMed ID: 38314858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients.
    Domínguez-Sosa MS; Cabrera-Ramírez MS; Marrero-Ramos MDC; Dávila-Quintana D; Cabrera-López C; González Cuervo H; Benítez Del Rosario JJ; Carrillo-Díaz T
    Ann Med; 2024 Dec; 56(1):2411018. PubMed ID: 39364704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care.
    Galletti C; Ciodaro F; Barbieri MA; Gambino F; Ferrisi MG; Portelli D; Catalano N; Spina E; Freni F; Galletti B
    Am J Otolaryngol; 2024; 45(4):104329. PubMed ID: 38696895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review.
    Nitro L; Bulfamante AM; Rosso C; Saibene AM; Arnone F; Felisati G; Pipolo C
    Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):199-204. PubMed ID: 35880360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review.
    Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S
    Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy.
    Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic rhinosinusitis with nasal polyps-extension of dupilumab treatment intervals].
    Appel HM; Lochbaum R; Hoffmann TK; Hahn J
    HNO; 2024 Jul; 72(7):499-503. PubMed ID: 38761229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis.
    Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q
    Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative real-world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients.
    De Corso E; Porru DP; Corbò M; Montuori C; De Maio G; Mastrapasqua RF; Panfili M; Spanu C; Di Bella GA; D'Agostino G; Rizzuti A; Passali GC; Galli J
    Clin Otolaryngol; 2024 Jul; 49(4):481-489. PubMed ID: 38711363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.
    Orlando P; Licci G; Kuitche D; Matucci A; Vultaggio A; Gallo O; Maggiore G
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1317-1324. PubMed ID: 37910208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan.
    Fujieda S; Matsune S; Takeno S; Asako M; Takeuchi M; Fujita H; Takahashi Y; Amin N; Deniz Y; Rowe P; Mannent L
    Laryngoscope; 2021 Jun; 131(6):E1770-E1777. PubMed ID: 33226139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Real-World Study Long-Term Clinical Results Using Dupilumab for Chronic Rhinosinusitis With Polyps.
    Kilty SJ; Lasso A
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241278659. PubMed ID: 39345032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps.
    Kilty SJ; Lasso A
    J Otolaryngol Head Neck Surg; 2022 Apr; 51(1):17. PubMed ID: 35468866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.